HJ445A
HJ445A is a potent MYOF inhibitor and binds to the MYOF-C2D domain with a KD of 0.17 μM. HJ445A potently repressed the proliferation of gastric cancer cells with IC50 values of 0.16 and 0.14 μM in MGC803 and MKN45, respectively. HJ445A demonstrates superior antitumor efficacy in vivo and can be used for cancer research[1].
Product Specifications
CAS Number
[3032441-59-8]
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hj445a.html
Concentration
10mM
Purity
98.31
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCC1=NN(C2=CC=CC(C(NCCCCN3N=CC=N3)=O)=C2)C(C4=CC=C(C=C4)OC)=N1
Molecular Formula
C24H27N7O2
Molecular Weight
445.52
References & Citations
[1]Haijun Gu, et al. Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer. J Med Chem. 2023 Dec 6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
P3285-12M2 100 µL
Peptide YY (PYY, Peptide Tyrosine Tyrosine, PYY1, PYY-I) (Biotin)
Ask
View Details 
MBS8432253-01 0.1 mg
Human ICOS/CD278 (C137S, C138S) Recombinant Protein His Tag Lyophilized
Ask
View Details MBS8432253-02 5x 0.1 mg
Human ICOS/CD278 (C137S, C138S) Recombinant Protein His Tag Lyophilized
Ask
View Details MBS6133395-01 0.1 mL
RFNG (Beta-1,3-N-acetylglucosaminyltransferase Radical Fringe, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) (AP)
Ask
View Details